KRISTINA BAUER: Open Payments
NPI 1285222380 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$338 in 14 payments from 10 companies in 2025. Trend: 2023 $440 · 2024 $523 · 2025 $338
Food & beverage: $338
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 2 | $64 |
| Astellas Pharma US Inc | 2 | $55 |
| Tempus AI, Inc | 2 | $54 |
| Daiichi Sankyo Inc. | 2 | $50 |
| ABBVIE INC. | 1 | $26 |
| Gilead Sciences, Inc. | 1 | $23 |
| Merck Sharp & Dohme LLC | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
| BeOne Medicines USA, Inc. | 1 | $15 |
Products named: KISQALI, Vyloy, XT CDX, DATROWAY, IMBRUVICA, Trodelvy, KEYTRUDA, JEMPERLI.
Industry payments across TX — which companies pay providers there.
